Litcius/Paper detail

Venous and arterial thromboembolism in patients with inflammatory bowel diseases

Antoni Stadnicki, Izabela Stadnicka

2021World Journal of Gastroenterology46 citationsDOIOpen Access PDF

Abstract

, an earlier first episode in life, high rates during both active and remission stages, higher recurrence rates, and poor prognosis. The increased likelihood of VTE in IBD patients may be related to surgery, the use of medications such as corticosteroids or tofacitinib, whereas infliximab is antithrombotic. Long-term complications of VTE can include post-thrombotic syndrome and high recurrence rate during post-hospital discharge. A global clot lysis assay may be useful in identifying patients with IBD who are at risk for TE. Many VTEs occur in IBD outpatients; therefore, outpatient prophylaxis in high-risk patients is recommended. It is crucial to continue focusing on prevention and adequate treatment of VTE in patients with IBD.

Topics & Concepts

MedicineInflammatory bowel diseaseAntithromboticInternal medicineUlcerative colitisInfliximabThrombosisVenous thrombosisCrohn's diseaseVenous thromboembolismGastroenterologyIntensive care medicineDiseaseInflammatory Bowel DiseaseVenous Thromboembolism Diagnosis and ManagementCentral Venous Catheters and Hemodialysis